Abstract 2021 marks the 30th anniversary of the original development of the Banff
Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists …

Antibody-Mediated Rejection of Solid-Organ Allografts This review focuses on current
standards for management of antibody-mediated rejection in solid-organ transplant …

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody …

Histologic analysis of the allograft biopsy specimen is the standard method used to
differentiate rejection from other injury in kidney transplants. Donor-derived cell-free DNA …

Detection of mismatched human leukocyte antigens by adaptive immune cells is considered
as the main cause of transplant rejection, leading to either T-cell mediated rejection or …

This meeting was organized by The Transplantation Society with the assistance of an
unconditional education grant from CSL Behring. CSL Behring had no involvement in the …

The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from
August 19–23, 2013, and was preceded by a 2‐day Latin American Symposium on …

Extending the functional integrity of renal allografts is the primary goal of transplant
medicine. The development of donor-specific antibodies (DSAs) posttransplantation leads to …

The availability of direct-acting antiviral agents for the treatment of hepatitis C virus (HCV)
infection has resulted in a profound shift in the approach to the management of this infection …

Antibody-mediated rejection (AMR) is a major cause of kidney graft loss, yet assessment of
individual risk at diagnosis is impeded by the lack of a reliable prognosis assay. Here, we …